TickerFactsScreenerDevelopers

UNITED THERAPEUTICS Corp (UTHR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $139.32M2008: $129.45M2009: $100.35M2010: $252.16M2011: $168.04M2012: $159.40M2013: $284.30M2014: $397.70M2015: $831.80M2016: $1.02B2017: $705.10M2018: $669.20M2019: $738.40M2020: $738.70M2021: $894.80M2022: $961.20M2023: $1.21B2024: $1.70B2025: $1.56B$1.56B
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.56B-8.3%
2024$1.70B+40.5%
2023$1.21B+25.6%
2022$961.20M+7.4%
2021$894.80M+21.1%
2020$738.70M+0.0%
2019$738.40M+10.3%
2018$669.20M-5.1%
2017$705.10M-31.1%
2016$1.02B+23.0%
2015$831.80M+109.2%
2014$397.70M+39.9%
2013$284.30M+78.4%
2012$159.40M-5.1%
2011$168.04M-33.4%
2010$252.16M+151.3%
2009$100.35M-22.5%
2008$129.45M-7.1%
2007$139.32M—